BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31393429)

  • 41. Are Bundled Payments a Viable Reimbursement Model for Revision Total Joint Arthroplasty?
    Courtney PM; Ashley BS; Hume EL; Kamath AF
    Clin Orthop Relat Res; 2016 Dec; 474(12):2714-2721. PubMed ID: 27357691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic Evaluation of Antibacterial Coatings on Healthcare Costs in First Year Following Total Joint Arthroplasty.
    Trentinaglia MT; Van Der Straeten C; Morelli I; Logoluso N; Drago L; RomanĂ² CL
    J Arthroplasty; 2018 Jun; 33(6):1656-1662. PubMed ID: 29530518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?
    Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
    Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct hospital cost determinants following hip and knee arthroplasty.
    Peel TN; Cheng AC; Liew D; Buising KL; Lisik J; Carroll KA; Choong PF; Dowsey MM
    Arthritis Care Res (Hoboken); 2015 May; 67(6):782-90. PubMed ID: 25470687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Technology-Assisted Hip and Knee Arthroplasties: An Analysis of Utilization Trends.
    Boylan M; Suchman K; Vigdorchik J; Slover J; Bosco J
    J Arthroplasty; 2018 Apr; 33(4):1019-1023. PubMed ID: 29290333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time-driven Activity-based Costing More Accurately Reflects Costs in Arthroplasty Surgery.
    Akhavan S; Ward L; Bozic KJ
    Clin Orthop Relat Res; 2016 Jan; 474(1):8-15. PubMed ID: 25721575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Financial impact of a capitation matrix system on total knee and total hip arthroplasty.
    Taylor B; Fankhauser RA; Fowler T
    J Arthroplasty; 2009 Aug; 24(5):783-8. PubMed ID: 18534540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physician preference items: what factors matter to surgeons? Does the vendor matter?
    Burns LR; Housman MG; Booth RE; Koenig AM
    Med Devices (Auckl); 2018; 11():39-49. PubMed ID: 29391836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global Budget Revenue on a Single Institution's Costs and Outcomes in Patients Undergoing Total Hip Arthroplasty.
    Delanois RE; Gwam CU; Cherian JJ; Etcheson JI; George NE; Schneider KA; Mont MA
    J Arthroplasty; 2018 Jul; 33(7):2043-2046. PubMed ID: 29534836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implementation of a Total Hip Arthroplasty Care Pathway at a High-Volume Health System: Effect on Length of Stay, Discharge Disposition, and 90-Day Complications.
    Featherall J; Brigati DP; Faour M; Messner W; Higuera CA
    J Arthroplasty; 2018 Jun; 33(6):1675-1680. PubMed ID: 29478678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the Length of Stay on the Cost of Total Knee and Total Hip Arthroplasty from 2002 to 2013.
    Molloy IB; Martin BI; Moschetti WE; Jevsevar DS
    J Bone Joint Surg Am; 2017 Mar; 99(5):402-407. PubMed ID: 28244911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early and Direct Rehab Transfer Leads to Significant Cost Savings and Decreased Hospital Length of Stay for Total Joint Arthroplasty in a Veteran Population.
    Stiegel KR; Valentine MT; Lash JG; Cardenas JM; Harrington MA; Green DM
    J Arthroplasty; 2021 May; 36(5):1478-1483. PubMed ID: 33546951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Total Joint Arthroplasty Surgical Day of the Week on Length of Stay and Readmissions: A Clinical Pathway Approach.
    Edwards PK; Hadden KB; Connelly JO; Barnes CL
    J Arthroplasty; 2016 Dec; 31(12):2726-2729. PubMed ID: 27378632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Cost Savings and Surgical Quality With Single-Vendor Procurement for Spinal Implants.
    Blackburn CW; Thompson NR; Tanenbaum JE; Passerallo AJ; Mroz TE; Steinmetz MP
    JAMA Netw Open; 2019 Nov; 2(11):e1915567. PubMed ID: 31730184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Revision total joint arthroplasty: does medicare reimbursement justify time spent?
    Ritter MA; Carr KD; Keating EM; Faris PN; Bankoff DL; Ireland PM
    Orthopedics; 1996 Feb; 19(2):137-9. PubMed ID: 8834288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excess cost associated with primary hip and knee joint arthroplasty surgical site infections: a driver to support investment in quality improvement strategies to reduce infection rates.
    Gow N; McGuinness C; Morris AJ; McLellan A; Morris JT; Roberts SA
    N Z Med J; 2016 Apr; 129(1432):51-8. PubMed ID: 27356252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does Total Ankle Arthroplasty Belong in the Comprehensive Care for Joint Replacement?
    Boylan MR; Riesgo AM; Paulino CB; Sheskier SC
    J Foot Ankle Surg; 2018; 57(1):69-73. PubMed ID: 29268905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Cost of Joint Replacement: Comparing Two Approaches to Evaluating Costs of Total Hip and Knee Arthroplasty.
    Palsis JA; Brehmer TS; Pellegrini VD; Drew JM; Sachs BL
    J Bone Joint Surg Am; 2018 Feb; 100(4):326-333. PubMed ID: 29462036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preclinical cost analysis of orthopaedic implants: a custom versus standard cementless femoral component for revision total hip arthroplasty.
    Chang PB; Robie BH; Bartel DL
    J Biomech; 1999 Dec; 32(12):1309-18. PubMed ID: 10569709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Placing a price on medical device innovation: the example of total knee arthroplasty.
    Suter LG; Paltiel AD; Rome BN; Solomon DH; Thornhill TS; Abrams SK; Katz JN; Losina E
    PLoS One; 2013; 8(5):e62709. PubMed ID: 23671626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.